Cite
HARVARD Citation
Fokkink, W. et al. (2016). Neonatal Fc receptor promoter gene polymorphism does not predict pharmacokinetics of IVIg or the clinical course of GBS. Annals of clinical and translational neurology. 3 (7), pp. 547-551. [Online].